REVOLADE®


Film-coated tablets
scheduling status
S4
registration number
44/26/0548, 44/26/0549
What REVOLADE® contains
Eltrombopag olamine 25 and 50 mg respectively.
other ingredients
Tablet core (25 mg and 50 mg): Magnesium stearate, mannitol, microcrystalline cellulose, povidone (K30), sodium starch glycolate Type A. Tablet coating (25 mg): Hypromellose, macrogol 400, polysorbate 80, titanium dioxide (E171). Tablet coating (50 mg): Hypromellose, iron oxide red (E172), iron oxide yellow (E172), macrogol 400, titanium dioxide (E171).
Therapeutic classification
A 26 Cytostatics.
© 2026 SAHPRA. ALL RIGHTS RESERVED